Scilex Holding Co (SCLXW) revenue by segment

SCLXWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLX

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$0.04−0.00 (-1.53%)

Close on Oct 30, 2026Market cap $17.50MP/E –Yield –

Scilex Holding Co revenue by segment

Scilex does not break out revenue by segment, region or product in the tagged data of its filings for this period type.